(1) Background: Cardiometabolic diseases are the most common cause of death worldwide. As part of a collaborative European study, this paper aims to explore the implementation of primary care selective-prevention services in five European countries. We assessed the implementation process of the selective-prevention services, participants’ cardiometabolic profile and risk and participants’ evaluation of the services, in terms of feasibility and impact in promoting a healthy lifestyle. (2) Methods: Eligible participants were primary care patients, 40–65 years of age, without any diagnosis of cardiometabolic disease. Two hundred patients were invited to participate per country. The extent to which participants adopted and completed the implementation of selective-prevention services was recorded. Patient demographics, lifestyle-related cardiometabolic risk factors and opinions on the implementation’s feasibility were also collected. (3) Results: Acceptance rates varied from 19.5% (n = 39/200) in Sweden to 100% (n = 200/200) in the Czech Republic. Risk assessment completion rates ranged from 65.4% (n = 70/107) in Greece to 100% (n = 39/39) in Sweden. On a ten-point scale, the median (25–75% quartile) of participant-reported implementation feasibility ranged from 7.4 (6.9–7.8) in Greece to 9.2 (8.2–9.9) in Sweden. Willingness to change lifestyle exceeded 80% in all countries. (4) Conclusions: A substantial variation in the implementation of selective-prevention receptiveness and patient risk profile was observed among countries. Our findings suggest that the design and implementation of behavior change cardiometabolic programmes in each country should be informed by the local context and provide some background evidence towards this direction, which can be even more relevant during the current pandemic period.

中文翻译：

---

在五个欧洲初级保健机构中实施针对心脏代谢疾病的选择性预防服务的高度可变性

（1）背景：心脏代谢疾病是全世界最常见的死亡原因。作为欧洲合作研究的一部分，本文旨在探讨在五个欧洲国家/地区实施初级保健选择性预防服务的情况。我们就促进健康生活方式的可行性和影响评估了选择性预防服务的实施过程，参与者的心脏代谢状况和风险以及参与者对服务的评估。（2）方法：符合条件的参与者是40-65岁的初级保健患者，没有任何心脏代谢疾病的诊断。每个国家/地区邀请了200名患者参加。记录了参与者采用和完成选择性预防服务的程度。患者人口统计资料 还收集了与生活方式有关的心脏代谢危险因素，以及对实施可行性的意见。（3）结果：接受率从瑞典的19.5％（n = 39/200）到捷克共和国的100％（n = 200/200）不等。风险评估完成率的范围从希腊的65.4％（n = 70/107）到瑞典的100％（n = 39/39）。在十点制范围内，参与者报告的实施可行性的中位数（25-75％四分位数）范围从希腊的7.4（6.9-7.8）到瑞典的9.2（8.2-9.9）。在所有国家/地区，改变生活方式的意愿均超过80％。（4）结论：在国家之间，选择性预防接受性和患者风险状况的实施存在很大差异。